Artificial intelligence startup Fractal announced on Wednesday that it had raised $ 360 million from private equity firm TPG.
Srikanth Velamakanni, Co-Founder and Group Chief Executive at Fractal, TechCrunch said the investment will earn the company unicorn status and a rating of “well over $ 1 billion.”
Fractal, the parent company of the AI healthcare company Qure.ai receives the funds through TPG Capital Asia. The transaction includes the primary investment and secondary stock purchase of Apax advised funds and is expected to close in the first quarter.
Based in Ghana mPharma, which operates public pharmacies that sell drugs and other health services in eight markets in Africa, has raised $ 35 million in Series D funding, according to TechCrunch.
The funds, consisting of $ 30 million in equity and $ 5 million in debt financing, will be used to build the company’s data infrastructure, recruit new employees, expand into current and new markets, and launch a pharmaceutical e-commerce platform used.
Kiddo, Maker of a portable remote patient monitoring device for children, raised $ 16 million in a Series A funding round led by Vive Collective.
The capital will be used to hire new employees in the US and Asia, develop partnerships with health systems and payers, and obtain FDA approval. In addition to the wearable, Kiddo’s tools include a coaching app for parents, telemedicine services and clinical decision support for providers.
“The adoption of telehealth services has accelerated during the pandemic, but doctors and parents who support children with chronic conditions still need real-time data to make decisions, such as seen right away,” said Dr. SKiddo chief medical officer Rishi Madhok in a statement.
“You can’t collect this data just by visiting it online, which is why the Kiddo RPM platform is an indispensable tool in treating chronic illnesses in children.”
ianacare, a digital platform for nurses to find resources, employee benefits, and other support, has raised $ 12.1 million in Series A funding.
The round was led by Greycroft with the participation of 8VC, SemperVirensVC, Able Partners and Brown Alumni Group as well as follow-up investments by Slow, Founder Collective, Indicator Ventures, Entree Capital, Cue Ball, Service Provider Capital and AARP.
The funds will be used to increase sales, team and operations.
“There are so many activities integrated into the care plan that the caregiving relatives are entitled to – such as medication management, transportation to and from appointments, managing nutritional needs, etc. Creating a real care infrastructure in the home environment requires access, knowledge and guidance, ”said Steven Lee, COO and co-founder of anacare.
“We found that there were thousands of resources and services out there, but they were very fragmented and difficult to find. The power of technology enables us to bring large systems together, enable easier connection and coordination, and deliver highly personalized experiences on a large scale. “
Headache, which provides employers with a preventive mental and behavioral health platform, raised $ 10 million in a Level Equity-led Series A round involving Westcap Management and Birchcliff Partners.
“Employers around the world were inadequately prepared for the pandemic from a mental health standpoint. Technology has done a great job building customized learning experiences for people to fill that gap, “said Dr. Ryan Todd, CEO and Co-Founder of Headversity, in a statement.
“Wherever the industry falls short, it helps to build a community and common language around mental health in our workplaces. We believe that the interconnection of personalized learning and team learning is changing the landscape of employee training and providing an unprecedented opportunity for companies to reach out to their entire workforce and build a safe culture. “
AI-based startup for drug discovery Protai emerged from the stealth on Wednesday with $ 8 million seed funding.
The round was chaired by Grove Ventures and Pitango HealthTech and aims to develop the company’s platform, expand its research programs and expand partnerships with pharmaceutical companies.
Strados Labs, Maker of a wearable respiratory health monitoring sensor, announced that it has raised $ 4.5 million in pre-Series A funding.
Investors in the round include SOSV, cultural (MD), Wavemaker360 Health, Blu Venture Investors and Broad Street Angels. The company’s flagship product, the RESP Smart Sensor Platform, received FDA 510 (k) approval at the end of 2020.
“This next round of funding will allow us to scale RESP, conduct decentralized clinical trials and strengthen our proprietary database of lung sounds and breathing patterns to set the standard for acoustic biomarkers,” said Nick Delmonico, co-founder and CEO of Strados, in one Explanation .
“The really exciting thing is that we are helping pharmaceutical companies with their studies by helping them quickly scale their digital therapeutics with our clinically validated measures for wheezing, coughing and other random breath sounds or CABS– which no other approved device can measure. “
